Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steinebach

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Biomolecules|June 27, 2024
Preclinical Evaluation of a Novel Series of Polyfluorinated Thalidomide Analogs in Drug-Resistant Multiple MyelomaBlaire E Barton, Matthew K Collins, Cindy H Chau, et al.
Molecules (Basel, Switzerland)|December 5, 2020
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide AnalogsMegan L Peach, Shaunna L Beedie, Cindy H Chau, et al.
Journal of Medicinal Chemistry|January 2, 2026
Discovery of Histone Deacetylase 8-Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological MalignanciesShiyang Zhai, Marie Kemkes, Cindy-Esther Kponomaizoun, et al.
Pharmaceutical Research|November 10, 2011
Radioactive holmium acetylacetonate microspheres for interstitial microbrachytherapy: an in vitro and in vivo stability studyWouter Bult, Hendrik de Leeuw, Olav M Steinebach, et al.
Zeitschrift Fur Die Gesamte Hygiene Und Ihre Grenzgebiete|September 1, 1971
[Aircraft noise as problem of hygiene in living and working conditions--medical observations on subjects residing near the central airport Berlin-Schönefeld using interviews]D Herrmann, K Horn, H Theodor, et al.
Chemical Science|November 2, 2020
Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degradersChristian Steinebach, Yuen Lam Dora Ng, Izidor Sosič, et al.
Nature Communications|February 24, 2022
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myelomaYuen Lam Dora Ng, Evelyn Ramberger, Stephan R Bohl, et al.
British Journal of Haematology|June 20, 2020
Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myelomaSaeko Kuwahara-Ota, Yuji Shimura, Christian Steinebach, et al.
Chemmedchem|December 16, 2025
A Facile Protocol for C(sp<sup>2</sup>)-C(sp<sup>3</sup>) Bond Formation Reactions Toward Functionalized E3 Ligase LigandsAnita Maksutova, Thomas M Geiger, Lorenzo Cianni, et al.
Journal of Medicinal Chemistry|June 18, 2025
Development and Characterization of the First Selective Class IIb Histone Deacetylase DegradersShiyang Zhai, Irina Honin, Linda Schäker-Hübner, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Biomolecules|June 27, 2024
Preclinical Evaluation of a Novel Series of Polyfluorinated Thalidomide Analogs in Drug-Resistant Multiple MyelomaBlaire E Barton, Matthew K Collins, Cindy H Chau, et al.
Molecules (Basel, Switzerland)|December 5, 2020
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide AnalogsMegan L Peach, Shaunna L Beedie, Cindy H Chau, et al.
Journal of Medicinal Chemistry|January 2, 2026
Discovery of Histone Deacetylase 8-Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological MalignanciesShiyang Zhai, Marie Kemkes, Cindy-Esther Kponomaizoun, et al.
Pharmaceutical Research|November 10, 2011
Radioactive holmium acetylacetonate microspheres for interstitial microbrachytherapy: an in vitro and in vivo stability studyWouter Bult, Hendrik de Leeuw, Olav M Steinebach, et al.
Zeitschrift Fur Die Gesamte Hygiene Und Ihre Grenzgebiete|September 1, 1971
[Aircraft noise as problem of hygiene in living and working conditions--medical observations on subjects residing near the central airport Berlin-Schönefeld using interviews]D Herrmann, K Horn, H Theodor, et al.
Chemical Science|November 2, 2020
Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degradersChristian Steinebach, Yuen Lam Dora Ng, Izidor Sosič, et al.
Nature Communications|February 24, 2022
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myelomaYuen Lam Dora Ng, Evelyn Ramberger, Stephan R Bohl, et al.
British Journal of Haematology|June 20, 2020
Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myelomaSaeko Kuwahara-Ota, Yuji Shimura, Christian Steinebach, et al.
Chemmedchem|December 16, 2025
A Facile Protocol for C(sp<sup>2</sup>)-C(sp<sup>3</sup>) Bond Formation Reactions Toward Functionalized E3 Ligase LigandsAnita Maksutova, Thomas M Geiger, Lorenzo Cianni, et al.
Journal of Medicinal Chemistry|June 18, 2025
Development and Characterization of the First Selective Class IIb Histone Deacetylase DegradersShiyang Zhai, Irina Honin, Linda Schäker-Hübner, et al.
Pageof 11